Skip to main content
. 2020 Sep 24;10(6):1345–1357. doi: 10.1007/s13555-020-00448-x

Table 4.

Comparison of oral minoxidil with other standard medical treatments

Study Drugs Duration of treatment Number of subjects in study Panel Total hair count Non-vellus hair count
This study Minoxidil oral 5 mg/day 24 weeks 30 100.0% 19.2% 23.5%
Olsen et al.a 5% Minoxidil solution, vs 2% minoxidil vs placebo 48 weeks 393 57.9% vs 40.8% vs 23.2% 12.3% vs 8.8 vs 2.6%
Olsen et al.b 5% Minoxidil foam, vs placebo 16 weeks 352 38.3% vs 5.2% 13.4% vs 3.4%
Roberts et al.c Finasteride 1 mg/day, vs placebo 12 months 693 54% vs 3% 9.0% vs − 2.1
Neste et al.d Finasteride 1 mg/day, vs placebo 48 weeks 212 7.2 vs − 10.1 (8.3% better)
Harcha et al.e Dutasteride 0.5 mg/day vs finasteride 1 mg/day vs placebo 24 weeks 153 47% vs 36% vs 7% 11.67% vs 7.4% vs − 0.64%

aOlsen EA et al. J Am Acad Dermatol. 2002;47(3):377–85

bOlsen EA et al. J Am Acad Dermatol. 2007;57(5):767–74

cRoberts JL et al. J Am Acad Dermatol. 1999;41(4):555–63

dNeste D et al. Br J Dermatol. 2000;143(4):804–810

eHarcha WG et al. J Am Acad Dermatol. 2014;70(3):489–98